Search - tctmd.com

Displaying 1 - 20 of 86

Sort: Relevancy | Date

Presentation Miami Valves 2024

New Devices For Left Atrial Appendage Closure

Presenter: Saibal Kar

February 03, 2024

Presentation Miami Valves 2023

LAAO with the Lambre device

Presenter: Fabio S. de Brito Jr.

February 04, 2023

Presentation TCT 2022

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Presenter: Gauravpal Singh Gill

September 18, 2022

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

Presentation The Structural Heart Disease Summit 2018

Double Device Harmony for Challenging Anatomy

Presenter: Horst Sievert, Robert J. Sommer, David Meerkin

June 22, 2018

Presentation LAA 2017

Epicardial LAA closure (LARIAT): Device description, Results and Ongoing Studies

Presenter: Dhanunjaya Lakkireddy

July 22, 2017

Presentation LAA 2017

LAmbre: Device Description, Outcomes and Ongoing Studies

Presenter: Horst Sievert

July 22, 2017

Presentation LAA 2017

Ultraseal: Device Description, Outcomes and Ongoing Studies

Presenter: Josep Rodés-Cabau

July 22, 2017

Presentation LAA 2017

WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up

Presenter: Shephal Doshi

July 21, 2017

Presentation LAA 2017

The Spectrum of LAA Closure Devices: Similarities and Differences

Presenter: Horst Sievert

July 21, 2017

Presentation SIF 2017

LAA Closure with the WATCHMAN Device: A Perfect Case

Presenter: Ramon Quesada,

March 09, 2017

Presentation EuroPCR 2016

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Presenter: Martin Bergmann

May 18, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Presenter: J. Ledwoch

September 15, 2015

Presentation CICT 2015

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Patient Selection for the Watchman Device: The European Perspective

Presenter: Horst Sievert

August 01, 2015

Presentation

Safety of LAA Exclusion With the Lariat Device

Presenter: S. Chatterjee

May 04, 2015

Presentation

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

Presenter: Ram?n L?pez M?nguez

January 14, 2015

Presentation TCT 2014

PROLIPSIS

Presenter: Reda Ibrahim, Horst Sievert, Maurice Buchbinder, Eleftherios Sideris

September 16, 2014

Advertisement

New Devices For Left Atrial Appendage Closure

LAAO with the Lambre device

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Double Device Harmony for Challenging Anatomy

Epicardial LAA closure (LARIAT): Device description, Results and Ongoing Studies

LAmbre: Device Description, Outcomes and Ongoing Studies

Ultraseal: Device Description, Outcomes and Ongoing Studies

WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up

The Spectrum of LAA Closure Devices: Similarities and Differences

LAA Closure with the WATCHMAN Device: A Perfect Case

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

LAA Closure: First in Man With the Fourth-Generation Watchman Device

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Patient Selection for the Watchman Device: The European Perspective

Safety of LAA Exclusion With the Lariat Device

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

PROLIPSIS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content